Sign Up For Live
Surfing The NASH Tsunami Podcast now includes Live Audience attendance during recordings. We record Monday afternoons EST, with invites sent out on Fridays. Our host Roger Green will invite you into the epsiode to ask your questions and to address your feedback regarding anything and everything in Fatty Liver Disease. Our usual Surfers will also be there too… each week… every episode!

S2-E54.3 – Inside the Patient-Focused Drug Development Meeting: The Advocates’ Priorities

Global Liver Institute Founder, President and CEO Donna Cryer and her fellow patient and patient advocate Terri Milton join Stephen Harrison, Louise Campbell and Roger Green. They discussed the ground-breaking NASH Patient-Focused Drug Development meeting held on November 4, 2021. This included the advocates' priorities (both those who spoke in the PFDD session and others like our panelists) for changes in regulatory policy and programs.

In this conversation, the Surfers and the patient/patient advocate guests share divergent opinions about the relative value of drug development vs. support for non-invasive testing as the top advocacy priority. The group wraps up the episode (and this conversation) by discussing the one message each person hopes regulators took from the Patient-Focused Drug Development meeting.

Request Transcript of This Episode
Request Transcript

Stay In Touch with Surfing NASH

Stay In Touch
  • Name
  • Email & NPI
  • Country
  • Institution & Profession